ES2317938T3 - Uso de analogos de acidos grasos para el tratamiento y/o prevencion de enfermedades proliferativas de la piel. - Google Patents

Uso de analogos de acidos grasos para el tratamiento y/o prevencion de enfermedades proliferativas de la piel. Download PDF

Info

Publication number
ES2317938T3
ES2317938T3 ES01975050T ES01975050T ES2317938T3 ES 2317938 T3 ES2317938 T3 ES 2317938T3 ES 01975050 T ES01975050 T ES 01975050T ES 01975050 T ES01975050 T ES 01975050T ES 2317938 T3 ES2317938 T3 ES 2317938T3
Authority
ES
Spain
Prior art keywords
sub
carbon
alkyl
omega
baselineskip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01975050T
Other languages
English (en)
Spanish (es)
Inventor
Rolf Berge
Karsten Kristiansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thia Medica AS
Original Assignee
Thia Medica AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica AS filed Critical Thia Medica AS
Application granted granted Critical
Publication of ES2317938T3 publication Critical patent/ES2317938T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES01975050T 2000-09-27 2001-09-27 Uso de analogos de acidos grasos para el tratamiento y/o prevencion de enfermedades proliferativas de la piel. Expired - Lifetime ES2317938T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20004844A NO20004844L (no) 2000-09-27 2000-09-27 Fettsyre analoger for behandling av proliferative hudsykdommer
NO20004844 2000-09-27

Publications (1)

Publication Number Publication Date
ES2317938T3 true ES2317938T3 (es) 2009-05-01

Family

ID=19911618

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01975050T Expired - Lifetime ES2317938T3 (es) 2000-09-27 2001-09-27 Uso de analogos de acidos grasos para el tratamiento y/o prevencion de enfermedades proliferativas de la piel.

Country Status (16)

Country Link
US (1) US7230029B2 (enExample)
EP (1) EP1324756B1 (enExample)
JP (1) JP2004509917A (enExample)
KR (1) KR100905336B1 (enExample)
CN (1) CN100579521C (enExample)
AT (1) ATE418974T1 (enExample)
AU (2) AU2001294419B2 (enExample)
BR (1) BR0114137A (enExample)
CA (1) CA2421729A1 (enExample)
DE (1) DE60137243D1 (enExample)
ES (1) ES2317938T3 (enExample)
MX (1) MXPA03002629A (enExample)
NO (1) NO20004844L (enExample)
NZ (1) NZ524599A (enExample)
RU (1) RU2276602C2 (enExample)
WO (1) WO2002026218A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
JP5008258B2 (ja) 2002-06-20 2012-08-22 アイシー・ベック・リミテッド 含硫黄ホスホリピド誘導体
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
ES2660700T3 (es) * 2004-07-19 2018-03-23 Bergen Teknologioverføring As Composición que comprende aceites vegetales y/o de pescado y entidades de ácidos grasos no oxidables
EP2120916A4 (en) * 2007-02-05 2010-07-28 Children Youth And Women S Hea MODULATORS FOR THE PROLIFERATION OF T CELLS DEPENDENT OF ANTIGEN
US8602833B2 (en) 2009-08-06 2013-12-10 May Patents Ltd. Puzzle with conductive path
US11330714B2 (en) 2011-08-26 2022-05-10 Sphero, Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US9019718B2 (en) 2011-08-26 2015-04-28 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US9597607B2 (en) 2011-08-26 2017-03-21 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
USD732475S1 (en) 2012-11-19 2015-06-23 Littlebits Electronics Inc. Connector for modular electronic building system
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
WO2018065918A1 (en) 2016-10-04 2018-04-12 Mary Kay Inc. Methods and compositions for treating striae distensae
AU2019340475B2 (en) * 2018-09-14 2025-04-17 Université de Lausanne Methods for modulating regulatory T cells and inhibiting tumor growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
DE19516705C2 (de) * 1995-05-06 1997-10-02 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Substanzen
RU2123334C1 (ru) * 1997-03-05 1998-12-20 Тихоокеанский научно-исследовательский рыбохозяйственный центр Способ лечения псориаза
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
FR2792312B1 (fr) * 1999-04-15 2001-06-08 Oreal Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger

Also Published As

Publication number Publication date
EP1324756B1 (en) 2008-12-31
US7230029B2 (en) 2007-06-12
NO20004844D0 (no) 2000-09-27
WO2002026218A2 (en) 2002-04-04
AU2001294419B2 (en) 2005-12-01
ATE418974T1 (de) 2009-01-15
MXPA03002629A (es) 2004-05-24
JP2004509917A (ja) 2004-04-02
BR0114137A (pt) 2003-08-12
CA2421729A1 (en) 2002-04-04
NO20004844L (no) 2002-05-10
KR20030036843A (ko) 2003-05-09
KR100905336B1 (ko) 2009-07-01
CN1466453A (zh) 2004-01-07
RU2276602C2 (ru) 2006-05-20
US20040019108A1 (en) 2004-01-29
DE60137243D1 (de) 2009-02-12
WO2002026218A3 (en) 2002-06-13
HK1060692A1 (zh) 2004-08-20
CN100579521C (zh) 2010-01-13
NZ524599A (en) 2004-11-26
EP1324756A2 (en) 2003-07-09
AU9441901A (en) 2002-04-08

Similar Documents

Publication Publication Date Title
ES2317938T3 (es) Uso de analogos de acidos grasos para el tratamiento y/o prevencion de enfermedades proliferativas de la piel.
US5770582A (en) Pharmaceutical compositions containing deoxyribonucleosides for wound healing
JP5792057B2 (ja) 創傷治癒における瘢痕形成を低減するための組成物および方法
JP2008543854A (ja) 炎症状態を治療するための組成物および方法
AU758264B2 (en) Inorganic nitrite and organic acid in combination as topical antiviral composition
EP0682521A4 (en) PROCESS FOR THE TREATMENT WITH MISOPROSTOL OF MUCUSUS AND EPITHELIAL TISSUES WITH LESIONS.
US7572780B2 (en) Method and kit for reducing the symptoms of peripheral vascular disease
AU2001294419A1 (en) Fatty acid analogues for the treatment of proliferative skin disorders
US20080207679A1 (en) Glutathione peroxidase mimetics for the treatment of dermatoses
HK1005703A1 (en) Pharmaceutical composition containing deoxyribonucleosides for wound healing
HK1005703B (en) Pharmaceutical composition containing deoxyribonucleosides for wound healing
JP4252444B2 (ja) 傷の治療および再上皮形成のための糖蛋白質の使用
JPS6218A (ja) 皮膚疾患治療用組成物
ES2369854T3 (es) Sales de calcio para el tratamiento de la psoriasis, la dermatitis y la caspa.
JPS6045516A (ja) １α―ヒドロキシビタミンＤ３類を含有することを特徴とする抗炎症解熱鎮痛剤
TWI670071B (zh) 促進毛髮增長或促進毛髮細胞生長的組合物及其用途
CN112839661A (zh) 用于治疗异位钙化的肌醇磷酸酯类
RU2278689C2 (ru) Способ лечения трофических язв и длительно незаживающих гнойных ран
NO324555B1 (no) Anvendelse av fettsyreanaloger for a hindre og/eller behandle proliferative hudsykdommer.
BR102017002700A2 (pt) formulação farmacêutica contendo dietilcarbamazina para uso na profilaxia e no tratamento de doenças inflamatórias humanas e veterinárias
US10438128B2 (en) Treatment of autoimmune and inflammatory diseases with the arsenic compounds AS2O3 and/or AS2O5 administered locally
KR940021055A (ko) 비환상 폴리이소프레노이드계 세포분화유도제
WO2024236533A1 (en) Rutin, also named oxerutin, for the treatment of epidermolysis bullosa
KR20030005042A (ko) 면역학적 질환의 치료를 위한 배합 제제
JP2008520694A (ja) 非治癒性及び治癒遅延性の創傷及び潰瘍の治癒を促進させる組成物及び方法